logo
Primary Proliferative Responses to Peptides of HIV Gag p24
FeLV Envelope Protein (gp70) Variable Region 5 Causes Alterations in Calcium Homeostasis and Toxicity of Neurons
Maternal Serum Vitamin A Levels Are Not Associated With Mother-to-Child Transmission of HIV-1 in the United States
Cigarette Smoking and Maternal-Child HIV Transmission
Effect of Cigarette Smoking on HIV-Related Oral Lesions
Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 Infection
The Impact of Primary Central Nervous System Lymphoma in AIDS Patients : A Population-Based Autopsy Study From Oslo
Update on the Seroepidemiology of Human Immunodeficiency Virus in the United States Household Population : NHANES III, 1988-1994
CD4+ T-Lymphocyte Counts in HIV Infection : Are European Standards Applicable to African Patients?
Blood Collection on Filter Paper : A Practical Approach to Sample Collection for Studies of Perinatal HIV Transmission
Surveillance for Thrombocytopenia in Persons Infected With HIV : Results From the Multistate Adult and Adolescent Spectrum of Disease Project
Lifetime Costs of HIV/AIDS Medical Care
Author's Reply : Lifetime Costs of HIV/AIDS Medical Care
Author's Reply : Lifetime Losts of HIV/AIDS Medical Care
Author's Reply : Lifetime Costs of HIV/AIDS Medical Care
8th International Conference of Human Retrovirology : HTLV and Related Viruses
SAN MARINO CONFERENCES"Scientific research at the dawning of the Third Millenium" : CHRONIC VIRAL DISEASES ASSOCIATED WITH IMMUNODEFICIENCY, CANCER AND NEUROLOGICAL DISORDERS
Conference Committee
The National AIDS Malignancy Conference April 28-30, 1997 CONFERENCE PROGRAM
Overview of the epidemiology of malignancies associated with immune deficiency : S1
Viral Pathogenesis of AIDS Related Malignancies : S2
CERVICOVAGINAL HUMAN PAPILLOMAVIRUS INFECTION IN HIV-POSITIVE AND HIGH RISK HIV-NEGATIVE WOMEN : S3
PROGRESSION OF ANAL SQUAMOUS INTRAEPITHELIAL LESIONS IN HIV-POSITIVE AND HIV-NEGATIVE HOMOSEXUAL/BISEXUAL MEN : S3
EPIDEMIOLOGY OF MALIGNANCIES OTHER THAN KAPOSI'S SARCOMA AND NON-HODGKIN'S LYMPHOMA IN HIV INFECTION : S4
HPV AND CERVICAL CANCER : FROM PATHOGENESIS TO PREVENTION
Malignancies in HIV-infected Children : S6
PRELIMINARY RESULTS OF AIDS CLINICAL TRIALS GROUP (ACTG) STUDY #149: PHASE II TRIAL OF ABVD CHEMOTHERAPY WITH G-CSF IN HIV INFECTED PATIENTS WITH HODGKIN'S DISEASE (HD) : S7
CERVICAL CANCER IN HIV-INFECTED WOMEN : S8
AIDS associated tumors and HHV8 : S9
S10
S11
TREATMENT OF AIDS-RELATED KAPOSI'S SARCOMA : CLINICAL OVERVIEW
KSHV-encoded oncogenes and oncogenesis. : S13
Human Herpesvirus 8 - the Causative Agent of Kaposl's Sarcoma? : S14
LATENT AND LYTIC REPLICATION OF HHV8/KSHV : S15
NOVEL FEATURES OF THE GENOME OF KSHV/HHV8 : S16
THE ROLE OF HERPESVIRUSES IN IMMUNE DEFICIENCY-ASSOCIATED LYMPHOMAS : S17
IMMUNOTHERAPY FOR EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE : S18
S19
TREATMENT OF HIV NON-HODGKIN'S LYMPHOMA, A CLINICAL OVERVIEW : S20
CURRENT ISSUES IN AIDS MALIGNANCY RESEARCH : A COMMUNITY PERSPECTIVE
Risk factors for HHV8 seropositivity and progression to Kaposi's sarcoma in a cohort of homosexual men, 1981-96 : 1
ROUTE OF TRANSMISSION OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS : 2
RISK FACTORS FOR HIV-RELATED MALIGNANCIES IN CHILDREN : 3
Non-Hodgkin's lymphoma in HIV+ and HIV− homosexual men in the San Francisco Bay Area : Allergies, prior medication use, and sexual practices
A REVIEW OF THE AETIOLOGY OF SQUAMOUS CELL CARCINOMA OF THE CONJUNCTIVA, WITH PRELIMINARY RESULTS OF A CASE-CONTROL STUDY FROM KAMPALA, UGANDA : 5
ABNORMAL CERVICAL CYTOLOGY IN HIV INFECTED WOMEN : 6
RISK FACTORS FOR CHILDHOOD KAPOSI'S SARCOMA IN UGANDA : A CASE CONTROL STUDY
RATES OF NON-AIDS DEFINING CANCERS IN PEOPLE WITH AIDS : 8
THE TEN-YEAR CANCER AND HIV EXPERIENCE OF THE UMDNJUNIVERSITY HOSPITAL (UH) CANCER REGISTRY : EXCESS PROPORTIONS OF HODGKIN'S LYMPHOMA AND LUNG CANCER
INTRAEPITHELIAL NEOPLASIA OF THE ANOGENITAL AREA IN HIV INFECTED HOMOSEXUAL MEN : 10
HIV INFECTION AND ASSOCIATED IMMUNOSUPPRESSION ACCELERATES PROGRESSION OF HPV RELATED CERVICAL NEOPLASIA IN INJECTION DRUG USING WOMEN : 11
THE FREQUENCY AND CLINICAL CONSEQUENCES OF DISRUPTIONS ENCOUNTERED IN THE PLANNED CHEMOTHERAPY OF AIDS-RELATED KAPOSI'S SARCOMA : 12
A PHASE I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470(AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSI'S SARCOMA(KS) : 13
A MULTICENTER, PHASE II/III STUDY OF ATRAGEN™ (Tretinoin Liposomal) IN PATIENTS WITH AIDS-ASSOCIATED KAPOSI'S SARCOMA : 14
DOX-SL (STEALTH LIPOSOMAL DOXORUBICIN HCL) MAINTENANCE THERAPY AFTER RESPONSE IN AIDS-RELATED KAPOSI'S SARCOMA : 15
Prognosis of Kaposi's Sarcoma as an Initial and Later AIDS Associated Illness : 16
Stealth liposomal doxorubicin or bleomycin/vincristine for the treatment of AIDS-related Kaposi's sarcoma : 17
DETECTION OF HUMAN HERPESVIRUS 8 DNA IN BRONCHOALVEOLAR LAVAGE FLUID FROM HIV-INFECTED PATIENTS WITH AND WITHOUT PULMONARY KAPOSI'S SARCOMA : 18
VALIDATION AND REFINEMENT OF THE ACTG STAGING SYSTEM FOR AIDS-ASSOCIATED KAPOSI'S SARCOMA (KS) : 19
PRELIMINARY RESULTS OF A PHASE II STUDY OF ORAL THALIDOMIDE IN PATIENTS WITH HIV INFECTION AND KAPOSI'S SARCOMA (KS) : 20
VIRAL LOAD CHANGES IN PATIENTS UNDERGOING CHEMOTHERAPY FOR AIDS-KS : 21
KAPOSI'S SARCOMA IN WOMEN WITH HIV INFECTION : 22
SIGNIFICANT REGRESSION OF KAPOSPS SARCOMA FOLLOWING INITIATION OF AN EFFECTIVE ANTIRETROVIRAL COMBINATION TREATMENT : 23
KAPOSI'S SARCOMA RESPONSE CRITERIA : ISSUES IDENTIFIED BY THE NATIONAL CANCER INSTITUTE, FOOD AND DRUG ADMINISTRATION, AND THE AIDS MALIGNANCY CONSORTIUM
SEROPREVALENCE OF HHV-8 IN PATIENTS WITH AND At RISK FOR KAPOSI'S SARCOMA IN THE US AND BRAZIL : 25
RISK FACTORS FOR AIDS-KS AND CLASSIC-KS : CLUES FOR ROLES OF CYTOKINES
Presence of HHV-8 in the Sperm of HIV-1 Infected Individuals : 27
DETECTION OF HHV-8 DNA IN KAPOSI'S SARCOMAS FROM IMMUNOSUPPRESSED PATIENTS : 28
HUMAN HERPESVIRUS-8 (HHV-8) : EPIDEMIOLOGY AND CHARACTERIZATION OF VIRUS FROM KS-1 CELL LINE
RISK FACTORS FOR KAPOSI'S SARCOMA (KS) IN HIV SEROPOSITIVE SUBJECTS IN UGANDA : 30
31
HHV8 AND OTHER HERPES VIRUS IN BIOPSIES OF AIDS RELATED AND ENDEMIC KAPOSI'S SARCOMA (KS) AND MALIGNANT LYMPHOMA : 33
Frequency of HHV8 detection in peripheral blood cells in patients with Kaposi's sarcoma. : 32
Presence of HHV-8 DNA in semen of inmmunocompetent HIV-negative individuals from different geographical areas in Italy. : 34
CONSERVATION OF HHV-8 DNA SEQUENCES IN VARIOUS TYPES OF IMMUNOCOMPROMISED PATIENTS WITH KAPOSI'S SARCOMA (KS) : 35
DOES HHV-8 PLAY A ROLE IN THE PATHOGENESIS OF KAPOSI'S SARCOMA (KS)—THE STUDY OF THE EXPRESSION OF VIL-6 AND VCYCLIN D IN KS TUMOR LESIONS : 36
EXPRESSION OF KSHV/HHV 8 CYCLIN IN PRIMARY EFFUSION LYMPHOMAS AND KAPOSI'S SARCOMA : 37
KSHV LATENT AND LYTIC INFECTION IN KAPOSI'S SARCOMA LESIONS AND LYMPHOID TISSUE : 38
RETENTION AND EXPRESSION OF HUMAN HERPES VIRUS 8 (HHV-8) IN SPINDLE CELLS CULTURED FROM KAPOSI'S SARCOMA LESIONS : 39
DRUGS THAT INHIBIT HERPESVIRUS DNA SYNTHESIS BLOCK IN VITRO ACTIVATION OF THE KAPOSI'S SARCOMA-ASSOCIATED HERPES VIRUS(KSHV) IN PERIPHERAL BLOOD MONONUCLEAR CELLS. : 40
HUMAN HERPESVIRUS 8 (HHV-8) ENCODES A HOMOLOGUE OF CELLULAR CYCLIN D2 THAT IS EXPRESSED IN KAPOSI'S SARCOMA (KS) LESIONS AND POTENTIAL KS PROGENITORS. : 41
HUMAN HERPESVIRUS 8 (HHV-8) ENCODES A BCL-2 HOMOLOGUE THAT IS EXPRESSED IN KAPOSI'S SARCOMA. : 42
EXPRESSION OF ATP-BINDING CASSETTE TRANSPORTERS AND THEIR ROLE IN THE SECRETION OF BASIC FIBROBLAST GROWTH FACTOR AND CELL SURVIVAL/APOPTOSIS IN KAPOSI SARCOMA. : 43
LYMPHOCYTE ADHESION AND TRANSMIGRATION THROUGH KAPOSI'S SARCOMA CELLS. STUDY IN STATIC AND DYNAMIC FLOW MODELS. : 44
USE OF TROPISM-MODIFIED ADENOVIRUSES FOR TARGETED DNA DELIVERY TO AIDS-KS CELLS VIA THE FIBROBLAST GROWTH FACTOR-RECEPTOR PATHWAY. : 45
Soluble Recombinant HIV-1 Tat Shares Features with Heparin-Binding Growth Factors : 46
CHARACTERIZATION OF CYTOKINE INDUCED SIGNALING EVENTS IN KAPOSI'S SARCOMA : 47
48
IN VITRO MODEL OF KAPOSI'S SARCOMA PATHOGENESIS : 49
HIV-1 TAT PROTEIN IS A GROWTH FACTOR FOR MAMMARY ADENOCARCINOMA CELLS FROM TAT TRANSGENIC MICE : 50
C-REACTIVE PROTEIN (Crp) AND INTERLEUKIN 6 (IL6) IN HIV-RELATED CONDITIONS : 51
AZT IS A GENOTOXIC TRANSPLACENTAL CARCINOGEN IN ANIMAL MODELS : 52
PRIMARY HIV ISOLATES THAT ARE DUAL-TROPIC FOR THE CHEMOKINE RECEPTORS ccR5 AND cxcR4 (FUSIN, LESTR) : 53
IMMUNOLOGICAL UNDERSTANDING OF PHOTOPHERESIS AND CYTOKINE THERAPY OF AIDS : 54
GLIOMA-DERIVED SUPPRESSOR FACTOR (GSF) INDUCES DECREASED IL-12 AND INCREASED IL-10 PRODUCTION : 55
IMPACT OF HIV INFECTION ON RATES OF DEATH FROM CANCERS AMONG MEN AGED 25-44 YEARS IN THE UNITED STATES : 56
ANTIRETROVIRAL DNA VACCINE CONTROLLED RELEASE SYSTEM FROM POLY(D.L-LACTIDE-CO-GLYCOLIDE) MICROPARTICLES AGAINST HIV-1 : 57
AIDS MALIGNANCY PROGRAM : NEW INITIATIVES FROM THE NATIONAL CANCER INSTITUTE
NON AIDS-DEFINING (NAD) MALIGNANCIES IN HIV POSITIVE INDIVIDUALS. : 59
Dysplastic myeloma in HIV positive patients. A report of two cases. : 60
UNUSUAL CASES OF BREAST CANCER IN HIV INFECTED WOMEN : WOMEN'S INTERAGENCY HIV STUDY (WIHS).
LUNG CANCER IN HIV SETTING AFFECTS MAINLY YOUNG SMOKER INDIVIDUALSWITH ASYMPTOMATICHIV DISEASE AND IT REPRESENTS THE MAIN CAUSE OF DEATH IN THESE PATIENTS (PTS). : 62
EPIRUBICIN, BLEOMYCIN, VINBLASTINE AND PREDNISONE (EBVP) CHEMOTHERAPY(CT) IN COMBINATION WITH ANTIRETOVIRAL THERAPY AND PRIMARY USE OF G-CSF FOR PATIENTS (PTS) WITH HODGKIN'S DISEASE AND HIV INFECTION (HD-HIV). : 63
ABNORMAL ERYTHROPOIESIS IN AN HIV INFECTED POLYCYTHEMIA PATIENT : A CASE REPORT
Establishment, characterization and Scid mice injection of B-cell lines harboring HHV-8 and EBV from a spleen of an HIV infected patient with multicentric Castleman's disease. : 65
NEUROENDOCRINE CARCINOMA IN THREE AIDS PATIENTS : ANOTHER AIDS-RELATED MALIGNANCY?
VASCULAR ENDOTHELIAL GROWTH FACTOR/VASCULAR PERMEABILITY FACTOR (VEGF/VPF) IS AN AUTOCRINE GROWTH FACTOR FOR AIDS-KS : 67
HIV-1 Tat protein enhances angiogenesis and Kaposi's sarcoma (KS) development triggered by inflammatory cytokines (IC) or bFGF by engaging theαvβ3 integrin : 68
ACTIVATION OF HHV-8 (KSHV) BY HIV-1 TAT : 69
Th-1 cytokine profile in PBMC and tumor infiltrating lymphocytes (TIL) of HHV-8+ Kaposi's sarcoma (KS) patients : role of γIFN in KS development (an immune response to HHV-8 ?)
IN SITU DETECTION OF KAPOSI'S SARCOMA HERPESVIRUS / HUMAN HERPESVIRUS 8 (KSHV / HHV 8) AND EXPRESSION OF THE CYCLIN D HOMOLOG IN EARLY PATCH-STAGE LESIONS OF KAPOSI'S SARCOMA : 71
ISOLATION OF HUMAN HERPESVIRUS-8 (HHV-8) FROM PBMC OF AIDS-KS PATIENTS AND VIRAL TRANSMISSION TO PRIMARY CELL CULTURE : 72
HOST RANGE STUDIES OF HUMAN HERPESVIRUS 8 (HHV8) : 73
ANALYSIS OF HUMAN HERPESVIRUS-8 INFECTION IN CHILDREN AND ADULTS BY MEASURING SERUM ANTIBODIES TO A PEPTIDE OF A MINOR CAPSID PROTEIN OR BY PCR : 74
PRIMARY HUMAN HERPESVIRUS TYPE 8 (HHV-8) INFECTION OCCURS FOLLOWING ADOLESCENCE IN THE UNITED STATES : 75
A PHASE II STUDY OF THALIDOMIDE FOR KAPOSI'S SARCOMA : ACTIVITY AND CORRELATION WITHKSHV DNA LOAD
LOW DOSE PACLITAXEL (TAXOL⊙) IS HIGHLY EFFECTIVE IN THE TREATMENT OF PATIENTS WITH ADVANCED AIDS-RELATED KAPOSI'S SARCOMA : 77
FUMAGILLIN ANALOG (TNP-470) IN THE TREATMENT OF KAPOSI'S SARCOMA : A PHASE I AIDS CLINICAL TRIAL GROUP STUDY
EVIDENCE OF ACTIVITY OF VINORELBINE (VNR) IN PATIENTS (PTS) WITH PREVIOUSLY TREATED EPIDEMIC KAPOSI'S SARCOMA (KS) : 79
Relationship of HHV-8 Peripheral Blood Mononuclear Cell Burden to Immunodeficiency, Opportunistic Infections, Response to Therapy, and Stage of Kaposi's Sarcoma : 80
LACK OF EXPRESSION OF THE VIRAL IL-6 HOMOLOGUE IN KSHV-ASSOCIATED TUMORS : 81
KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS ENCODED A FUNCTIONAL CYCLIN : 82
Anti-apoptotic bcl-2 homologs encoded by Kaposi's sarcoma-associated virus and herpesvirus saimiri; a role during virus infections : 83
KSHV/HHV 8 ENCODES A CONSTITUTIVELY ACTIVE G. PROTEINCOUPLED RECEPTOR LINKED TO CELL PROLIFERATION : 84
IDENTIFICATION OF NOVEL CHEMICAL CLASSES WITH POTENTIAL UTILITY AGAINST AIDS-RELATED LYMPHOMA : 85
Oral Combination Chemotherapy (CT) in Conjunction with Filgrastim (G-CSF) in the Treatment of AIDS-related non-Hodgkin's Lymphoma (NHL) : 86
Opportunistic Infection and Immunologic Function in Patients with AIDS-Associated Lymphoma Treated with Chemotherapy : 87
INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) FOR HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA (NHL) : LONG-TERM FOLLOWUP AND ANALYSIS OF PROGNOSTIC FACTORS
PROGNOSTIC FACTORS IN THE TREATMENT OF HIV-ASSOCIATED NON-HODGKIN LYMPHOMA (HANHL) : ANALYSIS OF ACTG 142(LOW-DOSE VS. STANDARD-DOSE mBACOD + GM-CSF)
PHASE I TRIAL OF ANTI-CD22 RICIN-A-CHAIN IMMUNOTOXIN (IgG-RFB4-dgA) FOR TREATMENT OF AIDS-LYMPHOMA : 90
HIV-RELATED NON-HODGKIN'S LYMPHOMA : CHOP INDUCTION THERAPY AND INTERFERON-A-2B/ZIDOVUDINE MAINTENANCE THERAPY.
MITOGUAZONE DIHYDROCHLORIDE (MGBG) IN COMBINATION WITH LOW DOSE CHOP FOR THE TREATMENT OF NEWLY DIAGNOSED AIDS-RELATED LYMPHOMA : 92
T-CELL LYMPHOMAS IN PATIENTS WITH HIV INFECTION : A REPORT OF 5 CASES FROM A SINGLE INSTITUTION
AZOTHYMIDINE AND INTERFERON-α ARE ACTIVE IN AIDS-ASSOCIATED SMALL NONCLEAVED CELL LYMPHOMA BUT NOT LARGE CELL LYMPHOMA : 94
Long Term Follow-Up of CEOP in the Treatment of H.I.V. Related N.H.L. : 95
A PHASE II STUDY OF DAILY SUBCUTANEOUS (SQ) LOW DOSE INTERLEUKIN-2(IL-2) IN HIV-ASSOCIATED MALIGNANCIES. : 96
TREATMENT OF EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN HIV-INFECTED PATIENTS WITH FOSCARNET. : 97
Primary Central Nervous System Lymphomas in patients with Acquiered Immunodeficilency Syndrome (AIDS) : 98
ANALYSIS OF TH1/TH2 CYTOKINE GENE PROFILE DURING LOW DOSE IL-2 THERAPY IN PATIENTS WITH AIDS OR AIDS LYMPHOMA : 99
HIV-RELATED NON-HODGKIN'S LYMPHOMA (NHL) : CENTROBLASTIC LYMPHOMA (CL) IS ASSOCIATED WITH BETTER OUTCOME THAN OTHER HISTOLOGICAL SUBTYPES
Pharmacologic induction of Epstein-Barr Virus lytic cycle : Strategies for tumor therapy
INTENSIVE CHEMOTHERAPY for HIV-ASSOCIATED BURKITT'S LEUKEMIA LMB 86 (COP-COPADM) regimen : 102
INTENSIVE CHEMOTHERAPY and G-CSF for HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA(LNHIV-91 regimen) : 103
HIV VIRAL BURDEN (VB) DURING EPOCH CHEMOTHERAPY (CT) FOR HIV-RELATED LYMPHOMAS : 104
AIDS Associated NHL in an African-American Population : 105
HHV-8 SEROPREVALENCE AND DNA SEQUENCES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES AND NORMAL POPULATION FROM ITALY : 106
107
Long-term experience after cure of Helicobacter pylori infection in low grade gastric MALT lymphomas : A follow-up study on 50 patients.
NON HODGKIN'S LYMPHOMA IN AIDS : Findings from linking AIDS and cancer registries.
FACTORS DETERMINING HIV-INFECTED WOMEN'S ENROLLMENT IN A TRIAL FOR TREATMENT OF CIN : 110
CD4+ T CELL RESPONSES TO EBV NUCLEAR ANTIGENS : 111
PATHOBIOLOGY OF SIV-ASSOCIATED LYMPHOMA IN THE RHESUS MACAQUE : INCIDENCE OF MULTIPLE VIRAL INFECTIONS IN TUMORS
LYMPHOMAS AND B-CELL LEUKEMIAS OF CHILDREN WITH AIDS ARE INFREQUENTLY ASSOCIATED WITH MUTATIONS OR TRANSLOCATIONS OF C-MYC OR WITH EPSTEIN BARR VIRUS : 113
HIV insertional cis-activation of the protooncogene c-fes in AIDS associated lymphomagenesis : 114
DELETIONS AND MUTATIONS WITHIN THE NF-κB ACTIVATION DOMAIN OF THE LATENT MEMBRANE PROTEIN 1 (LMP1) ONCOGENE OCCUR DURING LONG TERM HIV-INFECTION. : 115
FREQUENT USAGE OF SPECIFIC IMMUNOGLOBULIN VH SEGMENTS IN GASTRIC LOW-GRADE B-CELL LYMPHOMAS OF MALT. : 116
AIDS-RELATED POLYMORPHIC LYMPHOPROLIFERATIVE DISORDERS. : 116A
Activity of single-chain antibodies that selectively block the expression of Bcl-2 and Bag-1 anti-apoptotic proteins. : 117
Construction and activity of an intracellular single-chain antibody against the latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV). : 118
MODULATION OF FAS-MEDIATED APOPTOSIS IN BURKITTS LYMPHOMA (BL) B CELLS BY CROSSLINKING OF THE SURFACE ANTIGEN RECEPTOR : 119
PTHrP IS OVEREXPRESSED IN AIDS-RELATED LYMPHOMA. : 120
ELEVATION OF SERUM SOLUBLE CD27 LEVELS IN AIDS AND AIDS-ASSOCIATED LYMPHOMA : 121
A SUCCESSFUL ENDOGENOUS IMMUNE RESPONSE TO EPSTEIN-BARR VIRUS-ASSOCIATED MONOCLONAL B-CELL LYMPHOMA : 122
123
124
HIV-1 infection of microvascular endothelial cells facilitates growth of AIDS associated B cell lymphomas : 125
INHIBITION OF LYMPHOMA USING RIBONUCLEOTIDE REDUCTASE INHIBITORS DIDOX OR TRIMIDOX IN THE MURINE IMMUNODEFICIENCY MAIDS MODEL : ALONE OR IN COMBINATION WITH ddI.
EXPANSION OF EPSTEIN-BARR VIRUS (EBV)-SPECIFIC CYTOTOXIC T CELLS (CTLs) IN GAS PERMEABLE CELL CULTURE BAGS : 127
CERVICAL CANCER AS AN AIDS-DEFINING ILLNESS : 128
The Combination of Retinoic Acid and Interferon-alpha for the Treatment of Lymphoproliferative Disorders in Children with Immunodeficiency Disorders : 129
VULVOVAGINAL WARTS AND NEOPLASIA IN HIV-POSITIVE WOMEN : 130
THE SENSITIVITY OF CERVICAL CYTOLOGY IN HIV-INFECTED WOMEN : 131
BENIGN AND MALIGNANT SMOOTH MUSCLE TUMORS CONTAINING EPSTEIN-BARR VIRUS IN CHILDREN WITH AIDS : 132
Malignancies associated with HIV-1 infection in children : One center's experience over 6 years
MULTIPLE TYPES OF HUMAN PAPILLOMAVIRUSES AMONG HIV-1-INFECTED WOMEN IN HAWAII : CLINICAL AND MOLECULAR GENETIC ANALYSES
Clonal HIV is present in a wide variety of HIV-associated malignancies and cell separation studies map the clone to tumor-associated macrophages : 135
CORRELATIVE MORPHOLOGIC AND MOLECULAR GENETIC ANALYSIS OF 75 AIDS-RELATED SYSTEMIC NON-HODGKIN LYMPHOMAS : 136
GENETIC ALTERATIONS AND EXPRESSION STATUS OF BCL-6 IN AIDS-RELATED LYMPHOMAS : RELATIONSHIP WITH EBV INFECTION AND IDENTIFICATION OF DISTINCT MOLECULAR PATHWAYS IN AIDS-LYMPHOMAGENESIS
SKEWED AND UNSTABLE B-CELL REPERTOIRE IN SERIAL BLOOD SAMPLES OF HIV INFECTED PATIENTS. POTENTIAL ROLE IN THE INDUCTION OF AIDS-ASSOCIATED LYMPHOMA : 138
EVIDENCE FOR SIGNAL TRANSDUCTION THROUGH THE TNF RECEPTOR PATHWAY IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS : 139
FUNCTIONAL ANALYSIS OF THE TUMOR SUPPRESSOR GENE P53 IN NON-HODGKIN'S LYMPHOMAS AND ATYPICAL LYMPHOPROLIFERATIVE DISORDERS RELATED TO AIDS : 140
LYMPHOMA DEVELOPMENT IN SIV INFECTED MONKEYS : 141
Cytokine gene transcription and growth regulation of B - NHL in Simian immunodeficiency virus (SIV)-infected monkeys : 142
THE SPECTRUM OF LYMPHOMAS CONTAINING KSHV/HHV 8 : 143
CYTOKINESIS OF AIDS ASSOCIATED PRIMARY EFFFUSION LYMPHOMAS : 144
EBV-DNA IN CSF AS A MARKER FOR NON-INVASIVE DIAGNOSIS OF AIDS-RELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA : 145
REVERSAL OF MALIGNANT CELL GROWTH PHENOTYPE BY HYDROXYUREA-INDUCED LOSS OF EPSTEIN-BARR VIRUS EPISOMES : 146
ADOPTIVE IMMUNOTHERAPY USING AUTOLOGOUS EBV_SPECIFIC CYTOTOXIC T LYMPHOCYTES IN AN HIV INFECTED PATIENT WITH REFRACTORY EPSTEIN BARR VIRUS EXPRESSING B CELL LYMPHOMA : 147
ANTISENSE GENE THERAPY DIRECTED AGAINST EBNA-1 IN EBVASSOCIATED B CELL LYMPHOMAS RESULTS IN POTENTIATION OF CHEMOTHERAPY IN VITRO AND DECREASED TUMOR VIRULENCE IN SCID MICE : 148
THERAPY OF HIV-RELATED NON-HODGKIN'S LYMPHOMA : AN EUROPEAN MULTICENTRIC RANDOMIZED STUDY IN PATIENTS STRATIFIED ACCORDING TO THEIR PROGNOSTIC FACTORS
RESULTS OF A TREATMENT PROTOCOL FOR CHILDREN WITH HIV AND NON-HODGKIN'S LYMPHOMAS (NHLS). : 150
Is Lymphocytic Interstitial Pneumonitis an Early Stage of MALT Lymphoma in HIV-Infected Pediatric Patients? : 151
Online Comprehensive Daily Summaries